sales@scalarmarketresearch.com |  +1-800-213-5170  (U.S./ Canada Toll-free) |  REGISTER |  SIGN IN

Home >> Reports >> patient derived xenograft pdx models market

report

Patient Derived Xenograft/PDX Models Market, by Type (Mice Models, Rat Models), Tumor Type (Gastrointestinal Tumor Models, Gynecological Tumor Models, Respiratory Tumor Models, Urological Tumor Models, Hematological Tumor Models, Other Tumor Models), Application (Pre-clinical Drug Development and Basic Cancer Research, Biomarker Analysis), End-user (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic & Research Institutions) – Global Revenue, Trends, Growth, Share, Size, and Forecast to 2022

HC416 October 2017 100+ FREE 10% CUSTOMIZATION

Patient derived tumor xenograft are created when the cancerous tissue from the primary tumor of the patient is directly implanted into an immunodeficient mouse. This technique provides solutions to challenges in cancer drug research such as positive tumor responses There is an increase in research and development activities in the oncology sector to understand and develop better techniques. This report studies the current and future aspects of the patient derived xenograft/PDX models market.

The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the patient derived xenograft/pdx models market. The scope of this report covers the patient derived xenograft/pdx models market by its major segments, which include the types, applications, and the major geographic regions.

KEY BENEFITS OF THE REPORT

  • In-depth analysis of the market ecosystem and its impact on the revenue growth
  • Understanding of the strategies that are being adopted by the key players in this market to stay competitive
  • Valuable insights into the key technological and market trends impacting this market

KEY PREMIUM INDUSTRY INSIGHTS

  • The patient derived xenograft models market is growing at a rapid pace during the forecasted period mainly because of growing need for personalized medicine for cancer treatment.
  • In addition, there is a continuous support from public and private entities for cancer treatment and there is an increase in research and development activities which is promoting the market growth.
  • However, high costs associated with xenograft techniques and stringent guidelines regarding the use of animals in cancer research are hampering the growth of PDX models.

The global patient derived xenograft/PDX models market is divided into four major geographical segments which are North America, Europe, Asia-Pacific, and Rest of the World (RoW). The North America region holds the highest market share and proves to be the largest revenue contributor. The region continues to dominate the global market because of growth in biomedical research, and rising preclinical activities by the pharmaceutical companies and clinical research organizations in the region. The growing stem cell region in Canada is boosting the market growth. The Europe region is also growing at a fast pace because of rising research and development activities in the medical arena.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s patient derived xenograft/pdx models market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the patient derived xenograft/pdx models market by the following segments:

  • PDX Models Market, by Type           
    • Mice Models
    • Rat Models
  • PDX Models Market, by Tumor Type
    • Gastrointestinal Tumor Models
    • Gynecological Tumor Models
    • Respiratory Tumor Models
    • Urological Tumor Models
    • Hematological Tumor Models
    • Other Tumor Models
  • PDX Models Market, by Application
    • Pre-clinical Drug Development and Basic Cancer Research
    • Biomarker Analysis
  • PDX Models Market, by End-user
    • Pharmaceutical & Biotechnology Companies
    • Contract Research Organizations
    • Academic & Research Institutions

KEY MARKET PLAYERS

Key players in the patient derived xenograft/pdx models market include:

  • Crown Bioscience Inc.
  • The Jackson Laboratory
  • Champions Oncology, Inc.
  • Charles River Laboratories International, Inc.
  • WuXi Apptec (Group of Subsidiaries Under WuXi Pharmatec)
  • ONCODESIGN
  • Horizon Discovery Group PLC  (Sage Labs, Inc.)
  • Pharmatest Services Ltd.
  • Hera Biolabs
  • EPO Berlin-buch GmbH

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

  • NORTH AMERICA
    • U.S.
    • Rest of North America
  • EUROPE
    • France
    • Germany
    • U.K
    • Rest of Europe
  • ASIA-PACIFIC
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • REST OF THE WORLD
    • Latin America
    • Middle East & Africa

TRENDING RELATED REPORT

Pharmacy Automation Market, by End-users (In-Patient Pharmacy Automation, Out-Patient Pharmacy Automation, Pharmacy Benefit Management Organisation, Retail Pharmacy Chain), Product (Automated Medication Dispensing Systems, Automated Packaging & Labeling Systems, Automated Medication Compounding Systems, Automated Storage and Retrieval Systems, Tabletop Counters, Other Systems) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022


  1. MARKET OVERVIEW
    1. Market Definitions
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Premium Industry Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
    2. Technology Roadmap
  5. PDX MODELS MARKET, BY TYPE
    1. Segment Share
    2. By Type           
      1. Mice Models
      2. Rat Models
  6. PDX MODELS MARKET, BY TUMOR TYPE
    1. Segment Share
    2. By Tumor Type
      1. Gastrointestinal Tumor Models
      2. Gynecological Tumor Models
      3. Respiratory Tumor Models
      4. Urological Tumor Models
      5. Hematological Tumor Models
      6. Other Tumor Models
  7. PDX MODELS MARKET, BY APPLICATION
    1. Segment Share
    2. By Application
      1. Pre-clinical Drug Development and Basic Cancer Research
      2. Biomarker Analysis
  8. PDX MODELS MARKET, BY END-USER
    1. Segment Share
    2. By End-user
      1. Pharmaceutical & Biotechnology Companies
      2. Contract Research Organizations
      3. Academic & Research Institutions
  9. PDX MODELS MARKET, BY GEOGRAPHY
    1. Segment Share
    2. North America
      1. By Regions
        1. U.S.
        2. Rest of North America
      2. By Type
      3. By Tumor Type
      4. By Application
      5. By End-user
    3. Europe
      1. By Regions
        1. France
        2. Germany
        3. U.K.
        4. Rest of Europe
      2. By Type
      3. By Tumor Type
      4. By Application
      5. By End-user
    4. Asia-Pacific
      1. By Regions
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By Type
      3. By Tumor Type
      4. By Application
      5. By End-user
    5. Rest of the World
      1. By Regions
        1. Latin America
        2. Middle East & Africa
      2. By Type
      3. By Tumor Type
      4. By Application
      5. By End-user
  10. COMPETITIVE LANDSCAPE
    1. Market Positioning of Key Players, 2016
    2. Key Innovators
  11. KEY MARKET PLAYERS
    1. Crown Bioscience Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    2. The Jackson Laboratory
      1. Overview
      2. Key Strategies
      3. Key Developments
    3. Champions Oncology, Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    4. Charles River Laboratories International, Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    5. WuXi Apptec (Group of Subsidiaries Under WuXi Pharmatec)
      1. Overview
      2. Key Strategies
      3. Key Developments
    6. ONCODESIGN
      1. Overview
      2. Key Strategies
      3. Key Developments
    7. Horizon Discovery Group PLC  (Sage Labs, Inc.)
      1. Overview
      2. Key Strategies
      3. Key Developments
    8. Pharmatest Services Ltd.
      1. Overview
      2. Key Strategies
      3. Key Developments
    9. Hera Biolabs
      1. Overview
      2. Key Strategies
      3. Key Developments
    10. EPO Berlin-buch GmbH
      1. Overview
      2. Key Strategies
      3. Key Developments
  12. SCALAR 360 DEGREE MARKET PERSPECTIVE
  13. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170

EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

Unparalleled Expertise

Our industry experts hold inimitable know-how across wide range of industry verticals

Assured Quality

We deliver high-quality, real-time and data-driven industry insights to our clients

24x7 Analyst Support

We offer pre-purchase and post-purchase support from our industry experts

Privacy & Security

All your personal information and confidential details are safe and secure with us